# Kiniksa Pharmaceuticals, Ltd. Class A Common Stock (KNSA)

KNSA hits 52-week and all-time highs, but social media buzz is dominated by music videos, not company news. This disconnect is creating a 'stock loser' perception despite strong financial metrics.

### About Kiniksa Pharmaceuticals, Ltd. Class A Common Stock
Kiniksa Pharmaceuticals, Ltd. Class A Common Stock (KNSA) is a biopharmaceutical company.  
Kiniksa Pharmaceuticals, Ltd. Class A Common Stock uses the ticker $KNSA for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Kiniksa Pharmaceuticals, Ltd. Class A Common Stock (KNSA) social dominance is up 28.57% from the previous week.
- Kiniksa Pharmaceuticals, Ltd. Class A Common Stock (KNSA) Galaxy Score™ is up 26.67% from the previous month.
- Kiniksa Pharmaceuticals, Ltd. Class A Common Stock (KNSA) engagements is up 159.4% from the previous week.
- Kiniksa Pharmaceuticals, Ltd. Class A Common Stock (KNSA) posts created is up 46.43% from the previous month.
- Kiniksa Pharmaceuticals, Ltd. Class A Common Stock Price hit a 52-Week high of $46.10 for the hour
- Kiniksa Pharmaceuticals, Ltd. Class A Common Stock Price hit an all time of $46.10 for the hour

### Price: $45.40
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$knsa/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$knsa/time-series/close.tsv)  
Despite reaching 52-week and all-time highs, KNSA is experiencing negative price action, likely due to a disconnect between positive company metrics and social media content that is heavily focused on music videos rather than company news, creating a perception of a 'stock loser'.  

24-Hour: 2.42%
7-Day: 5.29%
30-Day: 15.12%

1-Year High: $45.40 on 2026-02-13  
1-Year Low: $18.70 on 2025-04-10  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$knsa/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$knsa/time-series/alt_rank.tsv)  
Kiniksa Pharmaceuticals, Ltd. Class A Common Stock (KNSA) is currently AltRank #1,788 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +1,273  
[--] Month: [-----] +687  
[--] Months: [-----] +1,760  
[--] Year: [-----] +570  
1-Year High: [-----] on 2026-02-04  
1-Year Low: [--] on 2025-10-25  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$knsa/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$knsa/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +5  
[--] Month: [--] +8  
1-Year High: [--] on 2025-11-24  
1-Year Low: [--] on 2026-02-04  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$knsa/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$knsa/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [------] +159%  
[--] Month: [-------] -32%  
[--] Months: [---------] -54%  
[--] Year: [----------] +684%  
1-Year High: [-------] on 2025-04-11  
1-Year Low: [---] on 2025-03-02  

Engagements by network (24h):
X: [---]
Reddit: [--]
TikTok: [---]
Instagram: [--]
YouTube: [------]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$knsa/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$knsa/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] -27%  
[--] Month: [---] +92%  
[--] Months: [---] -44%  
[--] Year: [-----] +172%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-02-17  

Mentions by network (24h):
X: [--]
Reddit: [--]
TikTok: [--]
Instagram: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$knsa/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$knsa/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Kiniksa Pharmaceuticals, Ltd. Class A Common Stock (KNSA) in the last [--] hours which is up 69% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] -29%  
[--] Month: [---] +70%  
[--] Months: [---] -57%  
[--] Year: [-----] +250%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-02-17  

The most influential creators that mention Kiniksa Pharmaceuticals, Ltd. Class A Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@atimuzikresmi](/creator/youtube/atimuzikresmi)     | [--]    | [-------]   | [--]     | [-----]       |
| [@TheOptionsBull2](/creator/twitter/TheOptionsBull2) | [--]    | [---]       | [--]     | [--]           |

[View More](/list/creators/$knsa/100)
  
  
### Sentiment: 50%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$knsa/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$knsa/time-series/sentiment.tsv)  
Current Value: 50%  
Daily Average: 85%  
[--] Week: 100% no change  
[--] Month: 71% +31%  
[--] Months: 71% -23%  
[--] Year: 71% -29%  
1-Year High: 100% on 2025-02-15  
1-Year Low: 20% on 2026-01-06  

Most Supportive Themes:
- Positive Company Metrics: (5%) Despite the social media content focus, the company itself exhibits strong performance metrics, including a 52-week high and all-time high price.
  
Most Critical Themes:
- Disconnect Between Social Content and Company Performance: (100%) The prevalence of non-company-related content, particularly music videos, on social media platforms is creating a perception of a 'stock loser' despite positive financial indicators.
  
  
  
### Social Dominance: 0.00191%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$knsa/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$knsa/time-series/social_dominance.tsv)  
Current Value: 0.00191%  
Daily Average: 0.00607%  
[--] Week: 0.0009% +0.00019999999999999998%  
[--] Month: 0.0026% -0.0002999999999999999%  
[--] Months: 0.0026% -0.0076%  
[--] Year: 0.0026% -0.0004000000000000002%  
1-Year High: 0.034% on 2025-06-29  
1-Year Low: 0.0014% on 2026-01-01  
  
  
### Market Dominance: 0.00389%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$knsa/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$knsa/time-series/market_dominance.tsv)  
Current Value: 0.00389%  
Daily Average: 0%  
1-Year High: 0.151% on 2026-02-13  
1-Year Low: 0.00389% on 2026-02-14  
  
  
### Market Cap: $3,438,853,586
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$knsa/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$knsa/time-series/market_cap.tsv)  
Current Value: $3,438,853,586  
Daily Average: $3,128,131,634  
[--] Week: $3,470,687,805 +6.30%  
[--] Month: $3,438,853,586 +20%  
1-Year High: $3,438,853,586 on 2026-02-13  
1-Year Low: $2,805,201,041 on 2025-10-31  

### Top Kiniksa Pharmaceuticals, Ltd. Class A Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"@Alper_TeMuRi_ Afar kinik ve cepni Trkmenleri alevidir "  
[X Link](https://x.com/elfcl1/status/2022422417449325039) [@elfcl1](/creator/x/elfcl1) 2026-02-13T21:27Z [----] followers, [---] engagements


"Notable [--] Week Highs Cont. from Part [--] $ETR $EVRG $EWTX $EXC $FE $FET $FLS $FOR $FORM $FRO $FSLY $FTS $GEF $GIL $GRBK $GTES $GTX $GTY $HASI $HSHP $IDA $IMKTA $INSW $IPGP $IRD $KMI $KNSA $LINC $LMT $LNT $MCD $MGA $MTK $MITK $MNRO $MOFG $MRK $MWA $NAT $NATL $NCI Part [--] Cont. -"  
[X Link](https://x.com/MarcJacksonLA/status/2022362150308843690) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2026-02-13T17:28Z [----] followers, [---] engagements


"KINIKAS ELEKTROMOBILIS PO [--] MET: TIK PRABANGUS POWERBANK Kalbams su kinik elektromobili savininkais kurie jais vainja jau ne vienerius metus. Kaip pasikeit automobiliai per laik K parod reali eksploatacija baterijos programin ranga ir aptarnavimas Ar iandien jie vl rinktsi kinik elektromobil ar vis dlto ne Atsakymai - video epizode Su kodu AUTOISTORIJA15 - gauk 15% nuolaid vienai ataskaitai 👉 https://autoistorija.lt/ - atsakingas sprendimas ir joki netiktum Daugiau automobili apvalg 🎞 https://bit.ly/4grmtAG Instagram: https://www.instagram.com/autoplius.lt Facebook:"  
[YouTube Link](https://youtube.com/watch?v=ZOZI_qrxxGg) [@autopliuslt](/creator/youtube/autopliuslt) 2026-02-12T16:01Z 23.6K followers, [----] engagements


"canim oglum gle gle git gle gle gel ayagina ta gzne ya degmesin rabbime amanetsin Rabbim tm askerleri korusun #kesfetteyiz #denizli #kinik #cicektepe #kesfetbeninekar"  
[TikTok Link](https://www.tiktok.com/@03.gelincik.03/video/7604573701991976212) [@03.gelincik.03](/creator/tiktok/03.gelincik.03) 2026-02-08T19:09Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing